Rempe Stephen J. 4
4 · Cardiovascular Systems Inc · Filed Apr 27, 2023
Insider Transaction Report
Form 4
Rempe Stephen J.
Chief Human Resources Officer
Transactions
- Disposition to Issuer
Common Stock
2023-04-27$20.00/sh−8,561$171,220→ 0 total - Disposition to Issuer
Common Stock
2023-04-27$20.00/sh−75,659$1,513,180→ 8,561 total
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each share of unvested restricted stock became fully vested immediately prior to the effective time of the merger. Shares of restricted stock were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes.
- [F2]Converted pursuant to the Merger Agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes.